Overview
Curie Ahn is a primary care provider, practicing in Internal Medicine in Valhalla, New York. Dr. Ahn is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). Her top areas of expertise are Autosomal Dominant Polycystic Kidney Disease, Polycystic Kidney Disease, Chronic Kidney Disease, Kidney Transplant, and Islet Cell Transplantation.
Her clinical research consists of co-authoring 358 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles in the study of Renal Cell Carcinoma (RCC).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- EPO
- HMO
- PPO
- HMO
- POS
- PPO
- HMO
- POS
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Northeast Medical Group Inc
Richard Rhee is a primary care provider, practicing in Internal Medicine in Bridgeport, Connecticut. Dr. Rhee is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Wilms Tumor, Clear Cell Sarcoma, Renal Cell Carcinoma (RCC), and WT1-Related Wilms Tumor Syndromes.
Physician Affiliate Group Of New York PC
Dilshad Chagla is a primary care provider, practicing in Geriatrics and Internal Medicine in Bronx, New York. Dr. Chagla is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). Her top areas of expertise are Nephrosclerosis, Chromophobe Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), and WT1-Related Wilms Tumor Syndromes.
David Muller is a primary care provider, practicing in Internal Medicine in New York, New York. Dr. Muller is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Renal Cell Carcinoma (RCC), Lung Cancer, Anal Cancer, Prostatectomy, and Heart Transplant.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Autosomal Dominant Polycystic Kidney Disease
- Chronic Kidney DiseaseDr. Ahn isDistinguished. Learn about Chronic Kidney Disease.
- Kidney TransplantDr. Ahn isDistinguished. Learn about Kidney Transplant.
- Polycystic Kidney DiseaseDr. Ahn isDistinguished. Learn about Polycystic Kidney Disease.
- Advanced
- Islet Cell TransplantationDr. Ahn isAdvanced. Learn about Islet Cell Transplantation.
- Renovascular HypertensionDr. Ahn isAdvanced. Learn about Renovascular Hypertension.
- Wilson DiseaseDr. Ahn isAdvanced. Learn about Wilson Disease.
- Experienced
- AnemiaDr. Ahn isExperienced. Learn about Anemia.
- CalcinosisDr. Ahn isExperienced. Learn about Calcinosis.
- Coronary Heart DiseaseDr. Ahn isExperienced. Learn about Coronary Heart Disease.
- DeliriumDr. Ahn isExperienced. Learn about Delirium.
- Diabetic NephropathyDr. Ahn isExperienced. Learn about Diabetic Nephropathy.
- End-Stage Renal Disease (ESRD)Dr. Ahn isExperienced. Learn about End-Stage Renal Disease (ESRD).